Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041181 | SCV000064872 | likely benign | not specified | 2015-12-17 | criteria provided, single submitter | clinical testing | p.Pro244Pro in exon 8 of NEXN: This variant is not expected to have clinical sig nificance because it does not result in an amino acid change and it is not locat ed within the splice consensus sequence. It has been identified in 0.1% (74/665 28) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://ex ac.broadinstitute.org; dbSNP rs201171783). |
Gene |
RCV000041181 | SCV000236112 | benign | not specified | 2014-10-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000458710 | SCV000560166 | benign | Dilated cardiomyopathy 1CC; Hypertrophic cardiomyopathy 20 | 2025-01-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618507 | SCV000739947 | likely benign | Cardiovascular phenotype | 2016-04-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000769816 | SCV000901242 | benign | Cardiomyopathy | 2017-10-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000041181 | SCV004242137 | benign | not specified | 2023-12-10 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001529872 | SCV001744082 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000041181 | SCV001921556 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001529872 | SCV001956667 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529872 | SCV001974072 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004541207 | SCV004768215 | benign | NEXN-related disorder | 2019-03-27 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |